2-43896916-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_133259.4(LRPPRC):​c.3826-208A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0879 in 152,208 control chromosomes in the GnomAD database, including 671 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.088 ( 671 hom., cov: 32)

Consequence

LRPPRC
NM_133259.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.13

Publications

1 publications found
Variant links:
Genes affected
LRPPRC (HGNC:15714): (leucine rich pentatricopeptide repeat containing) This gene encodes a leucine-rich protein that has multiple pentatricopeptide repeats (PPR). The precise role of this protein is unknown but studies suggest it may play a role in cytoskeletal organization, vesicular transport, or in transcriptional regulation of both nuclear and mitochondrial genes. The protein localizes primarily to mitochondria and is predicted to have an N-terminal mitochondrial targeting sequence. Mutations in this gene are associated with the French-Canadian type of Leigh syndrome. [provided by RefSeq, Mar 2012]
LRPPRC Gene-Disease associations (from GenCC):
  • congenital lactic acidosis, Saguenay-Lac-Saint-Jean type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • cytochrome-c oxidase deficiency disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 2-43896916-T-C is Benign according to our data. Variant chr2-43896916-T-C is described in ClinVar as Benign. ClinVar VariationId is 684328.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.136 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRPPRCNM_133259.4 linkc.3826-208A>G intron_variant Intron 34 of 37 ENST00000260665.12 NP_573566.2 P42704E5KNY5
LRPPRCXM_006711915.3 linkc.3748-208A>G intron_variant Intron 34 of 37 XP_006711978.1
LRPPRCXM_047442809.1 linkc.3700-208A>G intron_variant Intron 34 of 37 XP_047298765.1
LRPPRCXR_007068563.1 linkn.3868-208A>G intron_variant Intron 34 of 37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRPPRCENST00000260665.12 linkc.3826-208A>G intron_variant Intron 34 of 37 1 NM_133259.4 ENSP00000260665.7 P42704

Frequencies

GnomAD3 genomes
AF:
0.0881
AC:
13394
AN:
152090
Hom.:
673
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0797
Gnomad AMI
AF:
0.148
Gnomad AMR
AF:
0.0554
Gnomad ASJ
AF:
0.127
Gnomad EAS
AF:
0.00559
Gnomad SAS
AF:
0.146
Gnomad FIN
AF:
0.0693
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.103
Gnomad OTH
AF:
0.0819
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0879
AC:
13383
AN:
152208
Hom.:
671
Cov.:
32
AF XY:
0.0874
AC XY:
6502
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0795
AC:
3302
AN:
41536
American (AMR)
AF:
0.0553
AC:
846
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.127
AC:
442
AN:
3470
East Asian (EAS)
AF:
0.00541
AC:
28
AN:
5180
South Asian (SAS)
AF:
0.145
AC:
698
AN:
4820
European-Finnish (FIN)
AF:
0.0693
AC:
734
AN:
10588
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.103
AC:
6992
AN:
68006
Other (OTH)
AF:
0.0810
AC:
171
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
637
1275
1912
2550
3187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0460
Hom.:
44
Bravo
AF:
0.0835
Asia WGS
AF:
0.0570
AC:
199
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.068
DANN
Benign
0.73
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10495910; hg19: chr2-44124055; API